Increase in the number of discovery research studies serves as one of the key driving factors of the cell analysis market. The role of cell analysis in drug discovery has expanded significantly over the years, with new technologies being introduced in the market that generate accurate results while minimizing the time required. This is also supplemented by technological advancements in the field of molecular biology, cell biology, and genomics.
The global Cell Analysis Market is projected to reach USD 28.6 billion by 2027 from USD 17.7 billion in 2022, at a CAGR of 10.1% during
the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946
Market Segmentation:
Based on product & service, the global market is
segmented into reagents & consumables, instruments, accessories, software,
and services. Cell analysis software serves as an attractive market space
attributed to the advancements made in cell analysis, specially in the areas of
flow cytometry and single-cell analysis. This has led to an increase in the
number of emerging companies entering this market space. As a result, the
software segment is projected to register the highest CAGR during the forecast period.
Based on technique, the global market is segmented
into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry,
high-content screening, and other techniques. The flow cytometry segment
accounted for the largest market share of in 2021. The flow cytometry technique
has gained significant traction across different analysis processes, including
single-cell analysis. This technique is able to perform simultaneous
measurement and analysis of distinct characteristics of single-cell particles when
they flow in a fluid stream of a light beam.
Based on process, the global market is segmented
into cell identification, cell viability, cell signaling pathway/signal
transduction, cell proliferation, cell counting & quality control, cell
interaction, cell structure study, target identification & validation, and
single-cell analysis. Cell analysis applications are expected to broaden across
the fields of therapeutics, research, and diagnostics attributed to the advent
of single-cell analysis. This has rendered this segment with the fastest growth
rate during the forecast period. Additionally, single-cell analysis serves as a
powerful tool to assess individual cells at multiple parameters, in a
heterogeneous cell population.
On the basis of end users, the market is segmented
into pharmaceutical & biotechnology companies, hospitals & clinical
testing laboratories, academic & research institutes, and other end users.
The demand for cell analysis products is set to elevate across in-house diagnostic
and research centers, in-house pathology centers, and reference laboratories;
collectively contributing to the fastest growth rate of hospitals &
clinical testing laboratories during the forecast period. The development of
highly specialized and complex cell-based assays is expected to supplement this
growth.
Regional
Analysis:
The global market is segmented into North America, Europe, Asia Pacific, Latin America,
and the Middle East and Africa.
The Asia Pacific market
is estimated to grow at the highest CAGR during the forecast period. Rapid
increase in the pharmaceutical & biopharmaceutical industries coupled with
affordable with cell analysis services are the key contributing factors to the
regional growth.
Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=157543946
Top key Players :
The cell analysis market is fragmented in nature
with prominent players operating in this market such as Danaher (US), Thermo
Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric
(US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan),
Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK),
Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US),
Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US),
PerkinElmer (US), Tecan Trading AG (Switzerland),
CELLINK (US), QIAGEN (Germany),
Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
